Mason Street Advisors’s Novartis NVS Stock Holding History

Mason Street Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-98,546	Closed	-$8.18M	–	1666
2014 Q4	$8.18M	Buy	98,546 +18,972	+24%	+$1.57M	0.06%	380
2014 Q3	$6.71M	Hold	79,574	–	–	0.05%	401
2014 Q2	$6.46M	Hold	79,574	–	–	0.05%	441
2014 Q1	$6.06M	Hold	79,574	–	–	0.05%	437
2013 Q4	$5.73M	Hold	79,574	–	–	0.05%	452
2013 Q3	$5.47M	Buy	+79,574	New	+$5.26M	0.06%	336

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mason Street Advisors's NVS Position: Q1 2015 in Review

Mason Street Advisors sold out of Novartis (NVS) in Q1 2015, closing a stake of 98,546 shares — an estimated $8.18M sold.

Mason Street Advisors first reported a position in NVS in Q3 2013 and held it in 6 quarters. The position peaked at $8.18M in Q4 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Mason Street Advisors reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 98,546 Novartis shares in Q1 2015, an estimated $8.18M.
Mason Street Advisors first reported a position in Novartis in Q3 2013 and held it in 6 quarters.
Mason Street Advisors's Novartis position peaked at $8.18M in Q4 2014.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.